Differences in disease presentation, treatment outcomes, and toxicities in African American patients treated with radiation therapy for prostate cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 6, 2012, Pages 566-571

  Shah, Chirag ^a   Jones, Pamela M ^a   Wallace, Michelle ^a   Kestin, Larry L ^a,b   Ghilezan, Mihai ^a,b   Fakhouri, Monty ^a   Jaiyesimi, Ishmael ^a,b   Ye, Hong ^a   Martinez, Alvaro ^a,b   Vicini, Frank ^a,b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

African American; health care disparities; prostate cancer; radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; BIOCHEMICAL FAILURE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; DYSURIA; EUROPEAN AMERICAN; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROSTATE CANCER; RACE DIFFERENCE; RADIATION INJURY; RECTUM HEMORRHAGE; REVIEW; SURVIVAL RATE; TENESMUS; TREATMENT OUTCOME; URETHRA STRICTURE; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE; URINE RETENTION; UROGENITAL TRACT TOXICITY;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CHI-SQUARE DISTRIBUTION; DIARRHEA; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; GASTROINTESTINAL HEMORRHAGE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM METASTASIS; PAIN; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RECTAL DISEASES; RECTUM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URETHRAL STRICTURE; URINATION DISORDERS;

EID: 84870248911     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182208262     Document Type: Review

References (18)

1. American Cancer Society. Cancer Facts & Figures for African Americans 2009-2010. Available at: Http://www.cancer.org/acs/ groups/content/@nho/ documents/document/cffaa20092010pdf. Accessed December 1, 2010.
2. Surveillance Epidemiology and End Results. SEER Cancer Statistics Review, 1975-2007. Available at: Http://seer.cancer. gov/csr/1975-2007/index.html. Accessed December 1, 2010.
3. Zagars GK, Pollack A, Pettaway CA. Prostate cancer in African- American men: Outcome following radiation therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys. 1998;42:517-523. (Pubitemid 28501099)
4. Morton RA. Racial differences in adenocarcinoma of the prostate in North American men. Urology. 1994;44:637-645.
5. Powell IJ. Prostate cancer in the African American: Is this a different disease? Semin Urol Oncol. 1998;16:221-226. (Pubitemid 28553369)
6. Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS.8/9/2006. Available at: Http://ctep.cancer. gov/protocoldevelopment/ electronic-applications/docs/ctcaev3.pdf. Accessed December 1, 2010.
7. Woods VD, Montgomery SB, Herring RP, et al. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men. J Natl Med Assoc. 2006;98:492-504.
8. Freedland SJ, Sutter ME, Naitoh J, et al. Clinical characteristics in black and white men with prostate cancer in an equal access medical center. Urology. 2000;55:387-390. (Pubitemid 30110590)
9. Optenberg SA, Thompson IM, Friedrichs P, et al. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995;274:1599-1605.
10. Roach M III, Lu J, Pilepich MV, et al. Long-term survival after radiotherapy alone: RADIATION Therapy Oncology Group prostate cancer trials. J Urol. 1999;161:864-868. (Pubitemid 29422384)
11. Rosser CJ, Kuban DA, Lee SJ, et al. Racial influence on biochemical disease-free survival in men treated with externalbeam radiotherapy for localized prostate cancer. J Natl Med Assoc. 2004;96:939-944. (Pubitemid 38823508)
12. Connell PP, Ignacio L, Haraf D, et al. Equivalent racial outcome after conformal radiotherapy for prostate cancer: A single departmental experience. J Clin Oncol. 2001;19:54-61. (Pubitemid 32063479)
13. Johnstone PA, Kane CJ, Sun L, et al. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: Radiation oncology report of the Department of Defense Center for Prostate Disease Research. Radiology. 2002;225:420-426. (Pubitemid 35239242)
14. Powell IJ, Schwartz K, Hussain M. Removal of the financial barrier to health care: Does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology. 1995;46: 825-830.
15. Pienta KJ, Demers R, Hoff M, et al. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. Urology. 1995;45:93-101.
16. Resnick MJ, Canter DJ, Guzzo TJ, et al. Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy? Urology. 2009;73:620-623.
17. Albain KS, Unger JM, Crowley JJ, et al. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101:984-992.
18. Lehto RH, Song L, Stein KF, et al. Factors influencing prostate cancer screening in African American men. West J Nurs Res. 2010;32:779-793.